As of 2024-12-14, the Relative Valuation of Quest Diagnostics Inc (DGX) is 238.37 USD. This relative valuation is based on P/E multiples. With the latest stock price at 155.00 USD, the upside of Quest Diagnostics Inc based on Relative Valuation is 53.8%.
The range of the Relative Valuation is 205.73 - 281.79 USD.
| Range | Selected | |
| Trailing P/E multiples | 29.4x - 37.4x | 32.3x |
| Forward P/E multiples | 22.9x - 29.0x | 26.0x |
| Fair Price | 205.73 - 281.79 | 238.37 |
| Upside | 32.7% - 81.8% | 53.8% |
| Date | P/E |
| 2024-12-13 | 20.57 |
| 2024-12-12 | 20.71 |
| 2024-12-11 | 20.66 |
| 2024-12-10 | 21.03 |
| 2024-12-09 | 21.00 |
| 2024-12-06 | 20.88 |
| 2024-12-05 | 21.04 |
| 2024-12-04 | 21.27 |
| 2024-12-03 | 21.49 |
| 2024-12-02 | 21.44 |
| 2024-11-29 | 21.59 |
| 2024-11-27 | 21.68 |
| 2024-11-26 | 21.54 |
| 2024-11-25 | 21.56 |
| 2024-11-22 | 21.71 |
| 2024-11-21 | 21.75 |
| 2024-11-20 | 21.41 |
| 2024-11-19 | 21.39 |
| 2024-11-18 | 21.52 |
| 2024-11-15 | 21.29 |
| 2024-11-14 | 20.82 |
| 2024-11-13 | 21.31 |
| 2024-11-12 | 21.46 |
| 2024-11-11 | 21.26 |
| 2024-11-08 | 21.15 |
| 2024-11-07 | 20.73 |
| 2024-11-06 | 20.60 |
| 2024-11-05 | 20.45 |
| 2024-11-04 | 20.48 |
| 2024-11-01 | 20.61 |
| 2024-10-31 | 20.55 |
| 2024-10-30 | 20.70 |
| 2024-10-29 | 20.70 |
| 2024-10-28 | 20.69 |
| 2024-10-25 | 20.58 |
| 2024-10-24 | 20.97 |
| 2024-10-23 | 20.85 |
| 2024-10-22 | 20.90 |
| 2024-10-21 | 19.56 |
| 2024-10-18 | 19.86 |
| 2024-10-17 | 19.77 |
| 2024-10-16 | 19.77 |
| 2024-10-15 | 19.82 |
| 2024-10-14 | 19.78 |
| 2024-10-11 | 19.73 |
| 2024-10-10 | 19.62 |
| 2024-10-09 | 19.78 |
| 2024-10-08 | 19.75 |
| 2024-10-07 | 19.50 |
| 2024-10-04 | 20.01 |